Logo
PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET ANALYSIS
  2. / Market Insights
  3. Peptide Receptor Radionuclide Therapy (PRRT) Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET ANALYSIS

Peptide Receptor Radionuclide Therapy (PRRT) Market, by Drug Class (Lutetium (Lu-177), Yttrium-90, Indium-111, and others), By Disease Indication (Pancreatic - Neuroendocrine Tumor, Gastrointestinal Tract - Neuroendocrine Tumor and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

  • Published In : May 2023
  • Code : CMI2731
  • Pages :170
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Key Players

Major players operating in the global Peptide Receptor Radionuclide Therapy (PRRT) Market include Novartis AG, Advanced Accelerator Applications, S.A, ITM Solucin and Australasian Gastro-Intestinal Trials Group.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Peptide Receptor Radionuclide Therapy (PRRT) Market to Surpass US$ 4,373.9 Mn by 2030
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.